BA
The Boeing Company
BA's fundamentals are strong: its operating margin went from −10% to 10% and revenue grew 18%. Its PE isn't a useful guide right now because of how its recent earnings were reported.
CTRM
Castor Maritime Inc.
There isn't enough reported data to score CTRM yet.
BA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Under pressure |
BA's profitability is currently healthy, and its revenue and cash flow are stable, but its balance sheet is under pressure.
CTRM Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Healthy | |
| Unavailable | |
| Strong |
CTRM's profitability and balance sheet are currently healthy. There isn't enough data to rate its revenue and cash flow.
BA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $172 | — |
| Cheap | 51x | $496 | +189% |
| Fair | 82x | $790 | +360% |
| Expensive | 91x | $876 | +411% |
Historical ranges are pointers, not guarantees.
BA has the edge over CTRM in the historical PE scenario, which offers more potential upside but is not a forecast.
CTRM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 0.4x | $1.31 | — |
| Cheap | 0.5x | $1.82 | +39% |
| Fair | 1x | $3.44 | +163% |
| Expensive | 1.9x | $6.31 | +382% |
Historical ranges are pointers, not guarantees.
CTRM's PE is 0.4x, but its earnings don't support one, so it isn't a reliable read right now.
BA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect BA to return to profit, with revenue growing. However, they disagree widely on these estimates.
CTRM Forward outlook
There aren't enough analyst estimates for CTRM to show an outlook.
BA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $9.66 | +$23.38 |
| Q2 2026 | $2.78 | +$19.33 |
| Q1 2026 | $2.53 | +$20.49 |
| Q4 2025 | $2.48 | +$20.84 |
| Q3 2025 | -$13.72 | -$0.83 |
| Q2 2025 | -$16.55 | -$10.93 |
| Q1 2025 | -$17.96 | -$14.42 |
| Q4 2024 | -$18.36 | -$14.69 |
BA has returned to profit: it earned $9.66 per share over the past year, after losing money the year before.
CTRM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $3.32 | +$6.89 |
| Q4 2025 | $0.36 | -5.3% |
| Q4 2024 | $0.38 | -78% |
| Q4 2023 | $1.70 | -86% |
| Q2 2023 | $9.50 | +9.2% |
| Q4 2022 | $12.50 | +166% |
CTRM has the edge over BA in the latest year-over-year earnings comparison.
BA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.2B | +3.9% |
| Q2 2026 | $24.6B | +8% |
| Q1 2026 | $22.2B | +14% |
| Q4 2025 | $23.9B | +57% |
| Q3 2025 | $23.3B | +30% |
| Q2 2025 | $22.7B | +35% |
| Q1 2025 | $19.5B | +18% |
| Q4 2024 | $15.2B | -31% |
BA's revenue has grown year over year for seven quarters in a row: $24.2B last quarter, up 3.9% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.5% | +22 points |
| Q2 2026 | 0.6% | +1.4 points |
| Q1 2026 | 2% | -0.3 points |
| Q4 2025 | 37% | +61 points |
| Q3 2025 | -21% | +12 points |
| Q2 2025 | -0.8% | +5.7 points |
| Q1 2025 | 2.4% | +2.9 points |
| Q4 2024 | -25% | -26 points |
BA's operating margin was 1.5% last quarter, up 22 points from the same quarter a year ago.
CTRM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $46.8M | +22% |
| Q4 2025 | $43.5M | +47% |
| Q2 2025 | $38.3M | +4.4% |
| Q4 2024 | $29.6M | -70% |
| Q2 2024 | $36.7M | -26% |
| Q4 2023 | $97.5M | -30% |
| Q2 2023 | $49.7M | -59% |
| Q4 2022 | $140M | +36% |
CTRM has the edge over BA in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 156% | +81 points |
| Q4 2025 | 36% | +14 points |
| Q2 2025 | -90% | -111 points |
| Q4 2024 | -20% | -74 points |
| Q2 2024 | 75% | +33 points |
| Q4 2023 | 23% | -23 points |
| Q2 2023 | 22% | -8 points |
| Q4 2022 | 54% | +65 points |
CTRM has the edge over BA on profitability, with a higher operating margin.
BA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $464M | +95% |
| Q2 2026 | $631M | +$831M |
| Q1 2026 | -$1.5B | +$836M |
| Q4 2025 | $375M | +$4.5B |
| Q3 2025 | $238M | +$2.2B |
| Q2 2025 | -$200M | +$4.1B |
| Q1 2025 | -$2.3B | +$1.6B |
| Q4 2024 | -$4.1B | -239% |
BA's free cash flow has turned positive after six years mostly in the red: $16M over the past year.
CTRM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$62.8M | -$58.6M |
| Q4 2025 | $13.6M | +$67.7M |
| Q2 2025 | -$4.2M | -118% |
| Q4 2024 | -$54.1M | -351% |
| Q2 2024 | $23.8M | +186% |
| Q4 2023 | $21.6M | +22% |
| Q2 2023 | $8.3M | -72% |
| Q4 2022 | $17.6M | +$64.4M |
CTRM's free cash flow was −$108M over the past year, against $71M the year before.
BA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +2.1M shares |
| 1 year | +4.3% | +32.8M shares |
| 3 years | +31% | +186M shares |
| 5 years | +35% | +204M shares |
| Available history | +40% | +227M shares |
BA has the edge over CTRM on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
CTRM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +502% | +48.5M shares |
| 1 year | +514% | +48.7M shares |
| 3 years | +242296% | +58.2M shares |
CTRM has 58M diluted shares, up 514% from a year ago.
BA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.0x | Elevated |
| Q2 2026 | 5.7x | High |
| Q1 2026 | 6.0x | High |
| Q4 2025 | 6.9x | High |
| Q2 2024 | 361.8x | High |
| Q1 2024 | 36.1x | High |
| Q4 2023 | 36.4x | High |
| Q3 2023 | 96.1x | High |
BA's net debt is about 3.0 years of its operating earnings (EBITDA), down from more than 20 years a year ago.
CTRM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2023 | -0.6x | Net Cash |
| Q2 2023 | 0.8x | Very low |
| Q4 2022 | 0.1x | Very low |
| Q2 2022 | 0.3x | Very low |
| Q4 2021 | 0.9x | Very low |
| Q2 2021 | 0.3x | Very low |
| Q4 2020 | 1.8x | Healthy |
CTRM has more cash than debt.
BA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.1 | Neutral |
| Stochastic | 9.6 | Oversold |
BA's weekly RSI is 31 (neutral) and its Stochastic is 10 (oversold).
CTRM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 29.4 | Oversold |
| Stochastic | 4.8 | Oversold |
CTRM's weekly RSI is 29 (oversold) and its Stochastic is 5 (oversold).
BA PE vs Industrials Sector
| Metric | BA | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 24x | 26% below |
| PE % | 0 | 58 | 58 pts below |
BA is trading at 18x earnings, a 26% discount to the Industrials sector's median of 24x, though its earnings don't support one.
CTRM PE vs Industrials Sector
| Metric | CTRM | Sector median | Relative |
|---|---|---|---|
| PE | 0.4x | 24x | 98% below |
| PE % | 1 | 59 | 58 pts below |
CTRM has the edge over BA on valuation relative to its sector.
BA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $184.6 | 7.1% below |
| 20 week MA | $203.8 | 16% below |
| 50 week MA | $215.5 | 20% below |
| 100 week MA | $205.9 | 17% below |
| 200 week MA | $200.6 | 14% below |
CTRM has stronger trend alignment. BA is above 0 of 5 weekly averages versus CTRM above 0 of 4.
CTRM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.65 | 21% below |
| 20 week MA | $1.98 | 34% below |
| 50 week MA | $2.04 | 36% below |
| 100 week MA | $2.17 | 40% below |
CTRM is in a downtrend: it's below all four of its weekly moving averages, and 40% below its 100-week average.
BA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $330.1 | $217.2 | -34% |
| 2021 | $217.2 | $204.2 | -6% |
| 2022 | $204.2 | $189.1 | -7.4% |
| 2023 | $189.1 | $260.7 | +38% |
| 2024 | $260.7 | $180.7 | -31% |
| 2025 | $180.7 | $216.4 | +20% |
| 2026 YTD | $216.4 | $171.6 | -21% |
BA has the edge over CTRM on returns for 2026, with the stronger performance.
CTRM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2023 | $8.84 | $4.25 | -52% |
| 2024 | $4.25 | $2.88 | -32% |
| 2025 | $2.88 | $2.32 | -19% |
| 2026 YTD | $2.32 | $1.31 | -44% |
CTRM has finished every year since 2023 lower, and it's down 44% so far in 2026.